Cross-species vascular anatomy and sensitivity to intraocular pressure in glaucoma

Information

  • Research Project
  • 10211782
  • ApplicationId
    10211782
  • Core Project Number
    R01EY031708
  • Full Project Number
    1R01EY031708-01A1
  • Serial Number
    031708
  • FOA Number
    PA-20-185
  • Sub Project Id
  • Project Start Date
    9/30/2021 - 2 years ago
  • Project End Date
    8/31/2024 - 2 months from now
  • Program Officer Name
    LIBERMAN, ELLEN S
  • Budget Start Date
    9/30/2021 - 2 years ago
  • Budget End Date
    8/31/2022 - a year ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    9/23/2021 - 2 years ago

Cross-species vascular anatomy and sensitivity to intraocular pressure in glaucoma

SUMMARY Vascular dysfunction, with or without elevated intraocular pressure (IOP), is believed to be an important risk factor in glaucoma and other neuropathies. However, the link between vascular dysfunction and the mechanisms leading to the characteristic visual field defects in glaucoma is not fully understood. This is partly due to the lack of a solid quantitative understanding of the 3D architecture of the vasculature of the optic nerve head (ONH), its anatomical relationship with the load-bearing connective tissues, and how it is affected by IOP. Our overarching hypothesis is that features of the vasculature and its relationship with the connective tissues predispose certain ONH regions to compromised perfusion and that this susceptibility is amplified by elevated IOP. To test this hypothesis, we will sequentially collect in vivo, ex vivo, and histological 3D morphological and biomechanical data on vascular and connective tissues of the ONH in normal eyes and in eyes with experimental glaucoma (EG). We will focus on the critical lamina cribrosa (LC) region in three species: human, monkey (closest model to human, collagenous LC), and mouse (most used model, no collagenous LC). In Aim 1, we will map in 3D the vasculature and connective tissues of the ONHs of humans, monkeys, and mice, and analyze these maps quantitatively including by watershed analysis. We predict that zones of visual loss in early glaucoma will correspond to regions with the most vulnerable vascular supply, e.g., sparse capillaries with low connectivity and low perfusion redundancy. We postulate that, in primates, not all LC beams have a capillary, and conversely, that some capillaries are not within a robust collagen-rich beam. We will also address the clinically important question to which extent in vivo OCT angiography visualizes the smaller or deeper vessels inside the ONH. In Aim 2, we will perform ex vivo inflation tests on monkey and mouse eyes to quantify the effects of acute IOP elevation on vessel perfusion and biomechanics, and the LC beams support. Our preliminary data suggests that ?unprotected? vessels may be particularly vulnerable to mechanical distortion, which could, in turn, affect blood flow. In Aim 3, we will characterize the effects of chronic IOP elevation on vessels and beams. Specifically, we will compare eyes before and after chronic IOP elevation (EG), and with the contralateral control. This will allow us to discern characteristics that pre-dispose an eye to glaucoma from those that are the result of the disease. We will test the hypothesis that the patterns of vessel sensitivity to elevated IOP in mice (that have only a glial lamina) are different from those in primates. Combining multiple imaging modalities across the same ONHs in three species will provide cross-verification of the techniques, and deeper insights into the role of LC collagenous beams supporting the ONH vasculature under normal and elevated IOP. These experiments will help identifying ONH features that predict susceptibility to neural injury and vision loss.

IC Name
NATIONAL EYE INSTITUTE
  • Activity
    R01
  • Administering IC
    EY
  • Application Type
    1
  • Direct Cost Amount
    492468
  • Indirect Cost Amount
    75997
  • Total Cost
    568465
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    867
  • Ed Inst. Type
  • Funding ICs
    NEI:568465\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    DPVS
  • Study Section Name
    Diseases and Pathophysiology of the Visual System Study Section
  • Organization Name
    MASSACHUSETTS EYE AND EAR INFIRMARY
  • Organization Department
  • Organization DUNS
    073825945
  • Organization City
    BOSTON
  • Organization State
    MA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    021143002
  • Organization District
    UNITED STATES